Literature DB >> 26202416

Left atrial function is impaired in cirrhosis: a speckle tracking echocardiographic study.

Francisco Sampaio1,2, Joana Pimenta3, Nuno Bettencourt4,3, Ricardo Fontes-Carvalho4,3, Ana Paula Silva5, João Valente6, Paulo Bettencourt3, José Fraga5, Vasco Gama4.   

Abstract

PURPOSE: Abnormalities in left ventricular systolic and diastolic function have been described in patients with cirrhosis. There are no studies on left atrial (LA) function in these patients. We aimed to evaluate LA function in cirrhosis patients using myocardial deformation imaging.
METHODS: We included 111 hospitalized and ambulatory patients with cirrhosis and 18 healthy controls. A comprehensive echocardiographic evaluation was performed; LA strain was assessed using velocity vector imaging.
RESULTS: Peak atrial longitudinal strain at the end of ventricular systole was lower in patients [41.9 % (34.4-51.0) vs. 48.0 % (42.0-57.1), p = 0.02]. No differences were found in atrial strain before atrial contraction in patients and controls [17.5 % (14.3-22.4) vs. 20.7 % (14.1-26.3), p = 0.14]. On multivariate linear regression analysis, E' velocity was the only variable independently associated with peak atrial longitudinal strain (R (2) = 47 %). No correlation was found between the LA volume index (LAVI) and peak atrial longitudinal strain (r = -0.136, p = 0.219). Peak atrial longitudinal strain performed better than LAVI in identifying patients with elevated filling pressures (AUC = 0.81 vs. 0.52).
CONCLUSIONS: Patients with cirrhosis have abnormal atrial reservoir function, which may be related to the same factors associated with impaired ventricular relaxation. LA enlargement in cirrhosis may not reflect elevated filling pressures and should not be used as an isolated marker of diastolic dysfunction. The atrial "pump" function does not seem to be affected in cirrhosis patients.

Entities:  

Keywords:  Atrial function; Cirrhosis; Echocardiography; Heart failure; Speckle tracking imaging

Year:  2013        PMID: 26202416     DOI: 10.1007/s12072-013-9469-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  43 in total

1.  Evaluation of left atrial function in patients with coronary artery disease by two-dimensional strain and strain rate imaging.

Authors:  Ying-ying Liu; Ming-xing Xie; Jin-feng Xu; Xin-fang Wang; Qing Lv; Xiao-fang Lu; Jing Wang; Lin He; Ling-yun Fang; Jing Zhang
Journal:  Echocardiography       Date:  2011-10-04       Impact factor: 1.724

2.  Depressed atrial function in diastolic dysfunction: a speckle tracking imaging study.

Authors:  Umar A Khan; Giovanni de Simone; Jeffrey Hill; Dennis A Tighe; Gerard P Aurigemma
Journal:  Echocardiography       Date:  2012-12-12       Impact factor: 1.724

3.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

4.  Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging.

Authors:  Konstantin Kazankov; Peter Holland-Fischer; Niels H Andersen; Peter Torp; Erik Sloth; Niels K Aagaard; Hendrik Vilstrup
Journal:  Liver Int       Date:  2011-02-15       Impact factor: 5.828

5.  B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.

Authors:  Joana Pimenta; Cristiana Paulo; André Gomes; Sérgio Silva; Francisco Rocha-Gonçalves; Paulo Bettencourt
Journal:  Liver Int       Date:  2010-05-14       Impact factor: 5.828

6.  Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis.

Authors:  Alexandra Alexopoulou; George Papatheodoridis; Sophia Pouriki; Christina Chrysohoou; Leonidas Raftopoulos; Christodoulos Stefanadis; Dimitrios Pectasides
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

7.  Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.

Authors:  Francisco Sampaio; Joana Pimenta; Nuno Bettencourt; Ricardo Fontes-Carvalho; Ana P Silva; João Valente; Paulo Bettencourt; José Fraga; Vasco Gama
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

8.  Left ventricular diastolic function in liver cirrhosis.

Authors:  G Finucci; A Desideri; D Sacerdoti; M Bolognesi; C Merkel; P Angeli; A Gatta
Journal:  Scand J Gastroenterol       Date:  1996-03       Impact factor: 2.423

9.  LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.

Authors:  André Nazar; Mónica Guevara; Marta Sitges; Carlos Terra; Elsa Solà; Carina Guigou; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2012-09-16       Impact factor: 25.083

10.  Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy.

Authors:  Andrea Rossi; Mariantonietta Cicoira; Luisa Zanolla; Rita Sandrini; Giorgio Golia; Piero Zardini; Maurice Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

View more
  3 in total

1.  Speckle tracking echocardiography in cirrhosis: is it ready for prime time?

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2014-01-09       Impact factor: 6.047

Review 2.  Left ventricular function assessment in cirrhosis: Current methods and future directions.

Authors:  Francisco Sampaio; Joana Pimenta
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Assessment of cardiovascular physiology using dobutamine stress cardiovascular magnetic resonance reveals impaired contractile reserve in patients with cirrhotic cardiomyopathy.

Authors:  Francisco Sampaio; Pablo Lamata; Nuno Bettencourt; Sophie Charlotte Alt; Nuno Ferreira; Johannes Tammo Kowallick; Joana Pimenta; Shelby Kutty; José Fraga; Michael Steinmetz; Paulo Bettencourt; Vasco Gama; Andreas Schuster
Journal:  J Cardiovasc Magn Reson       Date:  2015-07-18       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.